{"blog": [], "keywords": [{"value": "Hedge Funds", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Ackman, William A", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "4", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Bankruptcies", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/28/business/dealbook/as-valeant-tumbles-so-does-billackmans-hedge-fund-herd.html", "document_type": "article", "byline": {"person": [{"lastname": "STEVENSON", "firstname": "Alexandra", "role": "reported", "organization": "", "rank": 1}, {"lastname": "GOLDSTEIN", "firstname": "Matthew", "role": "reported", "organization": "", "rank": 2}], "original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "legacy": {"wide": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "xlargeheight": "480", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 480}, {"url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1333", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "pub_date": "2016-04-28T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "As Valeant Tumbles, So Does Billionaire\u2019s Hedge Fund Herd", "main": "As Valeant Tumbles, So Does Bill Ackman\u2019s Hedge Fund Herd"}, "print_page": "6", "snippet": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "_id": "57215bd738f0d83acb9a61f3", "slideshow_credits": null, "abstract": "Pershing Square Capital Management founder William A Ackman testifies at Senate hearing on Valeant Pharmaceuticals' drug pricing policies; his hedge fund, along with others, have lost billions of dollars on Valeant, which has seen its share price plummet 85 percent since 2015."}